Suppr超能文献

法布里病的心肺受累情况。

Cardiopulmonary involvement in Fabry's disease.

作者信息

Koskenvuo Juha W, Kantola Ilkka M, Nuutila Pirjo, Knuuti Juhani, Parkkola Riitta, Mononen Ilkka, Hurme Saija, Kalliokoski Riikka, Viikari Jorma S, Wendelin-Saarenhovi Maria, Kiviniemi Tuomas O, Hartiala Jaakko J

机构信息

Dept. of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Finland.

出版信息

Acta Cardiol. 2010 Apr;65(2):185-92. doi: 10.2143/AC.65.2.2047052.

Abstract

BACKGROUND

Fabry's disease is an X-linked lysosomal storage disease caused by deficiency of alpha-galactosidase A enzyme activity. Decreased enzyme activity leads to accumulation of glycosphingolipid in different tissues, including endothelial and smooth-muscle cells and cardiomyocytes.

OBJECTIVES

There is controversial data on cardiopulmonary involvement in Fabry's disease, because many reports are based on small and selected populations with Fabry's disease. Furthermore, the aetiology of cardiopulmonary symptoms in Fabry's disease is poorly understood.

METHODS

We studied cardiopulmonary involvement in seventeen patients with Fabry's disease (20-65 years, 6 men) using ECG, bicycle stress, cardiac magnetic resonance imaging, spirometry, diffusing capacity and pulmonary high-resolution computed tomography (HRCT) tests. Cardiopulmonary symptoms were compared to observed parameters in cardiopulmonary tests.

RESULTS

Left ventricular hypertrophy (LVH) and reduced exercise capacity are the most apparent cardiac changes in both genders with Fabry's disease. ECG parameters were normal when excluding changes related to LVH. Spirometry showed mild reduction in vital capacity and forced expiratory volume in one second (FEV I), and mean values in diffusing capacity tests were within normal limits. Generally, only slight morphological pulmonary changes were detected using pulmonary HRCT, and they were not associated with changes in pulmonary function. The self-reported amount of pulmonary symptoms associated only with lower ejection fraction (P < 0.001) and longer QRS-duration (P = 0.04) of all measured cardiopulmonary parameters, whereas cardiac symptoms have no statistically significant association with any of these parameters.

CONCLUSION

LVH and reduced exercise capacity are the most apparent cardiopulmonary changes in Fabry's disease but they have only a minor association to cardiopulmonary symptoms.Therefore, routine cardiopulmonary evaluation in Fabry's disease using echocardiography is maybe enough when integrated to counselling for aerobic exercise training.

摘要

背景

法布里病是一种X连锁溶酶体贮积病,由α-半乳糖苷酶A酶活性缺乏引起。酶活性降低导致糖鞘脂在不同组织中蓄积,包括内皮细胞、平滑肌细胞和心肌细胞。

目的

关于法布里病心肺受累情况的数据存在争议,因为许多报告基于法布里病的小样本特定人群。此外,法布里病心肺症状的病因尚不清楚。

方法

我们对17例法布里病患者(20 - 65岁,6例男性)进行了心肺受累情况研究,采用心电图、踏车运动试验、心脏磁共振成像、肺量计、弥散功能和肺部高分辨率计算机断层扫描(HRCT)检查。将心肺症状与心肺检查中观察到的参数进行比较。

结果

左心室肥厚(LVH)和运动能力下降是法布里病男女患者最明显的心脏变化。排除与LVH相关的变化后,心电图参数正常。肺量计显示肺活量和一秒用力呼气量(FEV₁)轻度降低,弥散功能测试平均值在正常范围内。一般来说,肺部HRCT仅检测到轻微的形态学改变,且与肺功能变化无关。自我报告的肺部症状数量仅与所有测量的心肺参数中较低的射血分数(P < 0.001)和较长的QRS时限(P = 0.04)相关,而心脏症状与这些参数均无统计学显著关联。

结论

LVH和运动能力下降是法布里病最明显的心肺变化,但它们与心肺症状的关联较小。因此,在法布里病中,将超声心动图用于常规心肺评估并结合有氧运动训练咨询可能就足够了。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验